Exelixis
EXEL
#1458
Rank
HK$116.39 B
Marketcap
HK$469.73
Share price
1.42%
Change (1 day)
56.50%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company